| Automated Gleason grading of prostate cancer tissue microarrays via deep learning E Arvaniti, KS Fricker, M Moret, N Rupp, T Hermanns, C Fankhauser, ... Scientific reports 8 (1), 12054, 2018 | 380 | 2018 |
| Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08) AJ Templeton, V Dutoit, R Cathomas, C Rothermundt, D Bärtschi, ... European urology 64 (1), 150-158, 2013 | 142 | 2013 |
| Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09) C Rothermundt, S Hayoz, AJ Templeton, R Winterhalder, RT Strebel, ... European urology 66 (3), 468-474, 2014 | 134 | 2014 |
| Diagnostic Accuracy of Multiparametric MRI versus 68Ga-PSMA-11 PET/MRI for Extracapsular Extension and Seminal Vesicle Invasion in … UJ Muehlematter, IA Burger, AS Becker, K Schawkat, AM Hötker, ... Radiology 293 (2), 350-358, 2019 | 100 | 2019 |
| A high-performance system for robust stain normalization of whole-slide images in histopathology A Anghel, M Stanisavljevic, S Andani, N Papandreou, JH Rüschoff, P Wild, ... Frontiers in medicine 6, 193, 2019 | 88 | 2019 |
| Senescence reprogramming by TIMP1 deficiency promotes prostate cancer metastasis I Guccini, A Revandkar, M D'Ambrosio, M Colucci, E Pasquini, S Mosole, ... Cancer cell 39 (1), 68-82. e9, 2021 | 86 | 2021 |
| Expression and mutation patterns of PBRM1, BAP1 and SETD2 mirror specific evolutionary subtypes in clear cell renal cell carcinoma S Bihr, R Ohashi, AL Moore, JH Rüschoff, C Beisel, T Hermanns, ... Neoplasia 21 (2), 247-256, 2019 | 63 | 2019 |
| Immunohistochemical PSMA expression patterns of primary prostate cancer tissue are associated with the detection rate of biochemical recurrence with 68Ga-PSMA-11-PET DA Ferraro, JH Rüschoff, UJ Muehlematter, B Kranzbühler, J Müller, ... Theranostics 10 (14), 6082, 2020 | 59 | 2020 |
| What’s behind 68Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression … JH Rüschoff, DA Ferraro, UJ Muehlematter, R Laudicella, T Hermanns, ... European Journal of Nuclear Medicine and Molecular Imaging 48, 4042-4053, 2021 | 57 | 2021 |
| Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study DA Ferraro, AS Becker, B Kranzbühler, I Mebert, A Baltensperger, ... European journal of nuclear medicine and molecular imaging, 1-10, 2021 | 56 | 2021 |
| Multi-region proteome analysis quantifies spatial heterogeneity of prostate tissue biomarkers T Guo, L Li, Q Zhong, NJ Rupp, K Charmpi, CE Wong, U Wagner, ... Life science alliance 1 (2), 2018 | 52 | 2018 |
| Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer CD Fankhauser, PJ Schüffler, S Gillessen, A Omlin, NJ Rupp, ... Oncotarget 9 (12), 10284, 2018 | 52 | 2018 |
| Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer C Poyet, L Buser, F Roudnicky, M Detmar, T Hermanns, D Mannhard, ... Journal of Clinical Pathology 68 (10), 819-824, 2015 | 51 | 2015 |
| 68Ga-PSMA-11 PET has the potential to improve patient selection for extended pelvic lymph node dissection in intermediate to high-risk prostate cancer DA Ferraro, UJ Muehlematter, HI Garcia Schüler, NJ Rupp, M Huellner, ... European journal of nuclear medicine and molecular imaging 47, 147-159, 2020 | 48 | 2020 |
| STRN-ALK rearranged malignant peritoneal mesothelioma with dramatic response following ceritinib treatment JH Rüschoff, E Gradhand, A Kahraman, H Rees, JL Ferguson, ... JCO precision oncology 3, 2019 | 48 | 2019 |
| Comparative analysis of mRNA and protein degradation in prostate tissues indicates high stability of proteins W Shao, T Guo, NC Toussaint, P Xue, U Wagner, L Li, K Charmpi, Y Zhu, ... Nature communications 10 (1), 2524, 2019 | 41 | 2019 |
| KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation K Ikenberg, N Valtcheva, S Brandt, Q Zhong, CE Wong, A Noske, ... The Journal of pathology 234 (2), 239-252, 2014 | 41 | 2014 |
| KRAS, BRAF, and TP53 deep sequencing for colorectal carcinoma patient diagnostics M Rechsteiner, A von Teichman, JH Rüschoff, N Fankhauser, ... The Journal of Molecular Diagnostics 15 (3), 299-311, 2013 | 37 | 2013 |
| Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity Q Zhong, JH Rüschoff, T Guo, M Gabrani, PJ Schüffler, M Rechsteiner, ... Scientific reports 6 (1), 24146, 2016 | 34 | 2016 |
| Ultra-deep sequencing confirms immunohistochemistry as a highly sensitive and specific method for detecting BRAF V600E mutations in … M Rössle, M Sigg, JH Rüschoff, PJ Wild, H Moch, A Weber, ... Virchows Archiv 463, 623-631, 2013 | 33 | 2013 |
